Instructions for authors
médecine/sciences offers high-quality review articles in French, covering all areas of biomedical research. The articles are aimed at a large readership of researchers, scientists and clinicians researchers, teachers, students and medical doctors, from different fields. m/s is not a primary publication, and thus will not consider unpublished data. The articles should be written IN FRENCH and satisfy both literary and scientific requirements.
The articles are indexed in PubMed since 2003, with the exception of "Brèves" (very short News).
Three sections can be found in m/s:
- Reviews on a precise topic written by specialists in the field. Beyond the report of facts, these reviews must propose a real discussion of the scientific results. In this section can also be found Technical Reports (presentation of newly developed biomedical techniques).
- The Forum section offers articles of reflection, debating important issues at the interface between science and society, essays on history of science, public health, or reactions to published articles. m/s also publishes lists of facts or figures/statistics covering topics in the fields of epidemiology, demography, health economics, etc.
- The magazine reflects the latest scientific actuality, reporting on original results published recently. It consists mainly of News, solicited or unsolicited, and "Brèves" (very short News).
All articles must be submitted electronically via the Fontisworks system (http://msc.fontismedia.com).
Reviews and texts of the Forum section:
The articles should contain between 15, 000 and 20,000 characters (including spaces, excluding references), up to 30-40 references and 3-5 illustrations (figures and tables). They should be divided into paragraphs with titles and subtitles.
The authors should also submit an abstract IN FRENCH of about 700 characters designed to give a quick overview of the subject, and a title and an abstract IN ENGLISH of about 1,000 characters, which will appear in PubMed.
The authors should mention related articles previously published in m/s.The reviews should also be accompanied by a graphical abstract that will appear on m/s website. This figure should convey concisely and visually the main message of the article, and be submitted with the other figures of the article (specifying 'Graphical abstract').
News:The News should contain between 6,000 and 10,000 characters (including spaces, references excluded), up to 10 references and 1-2 figures. A title IN FRENCH and a title IN ENGLISH should be provided. No abstract or graphical abstract are required. The text can be divided into paragraphs with titles and subtitles. The "Brèves" should not exceed 2000 characters (including spaces), with a maximum of 5 references (mentioning only the first author and references, e.g. Dupont T, et al. Science 2010 ; 352 : 458-9.)
Authors should comply with the few following basic rules:
- define the acronyms used in the text inside parentheses and use italics in the case of an english name. E.g. IL-1 (interleukine 1), MAPK (mitogen-activated protein kinases);
- all technical details, methodological precisions, or additional information required to understand the text should be presented in footnotes, in a glossary, in a table, or in a text box (inset). All references must be listed in the main reference list.
Information about all the authors should be provided during the submission process: full name, institution, institution address, phone number, fax, e-mail.
The text must be double-spaced, in font size 12. The text and tables should be submitted in Word format (.doc) and in pdf. Illustrations should be submitted in separate files. Tables and illustrations should be called in the text (e.g. Table I, Figure 1). References cited in the tables should be presented as follow: [Ref No.], and included in the list of references.
The figures must be submitted in Illustrator or PowerPoint format, the photos in high-quality jpeg or tif format. When necessary, a scale of the image must be included and its value defined in the legend. The text included in the illustrations should not contain capital letters, except for: (1) the first word of the sentences (e.g. Metabolic pathway; Response to the stimulation), (2) the acronyms, which will be defined in the legend, and (3) the name of the subparts (A, B, etc.).
Complete and detailed legends of the figures and tables should be integrated at the end of the article. Illustrations are numbered with Arabic numerals (e.g. Figure 1) and the tables with Roman numerals (e.g. Table II). Illustrations reproduced or adapted from previously published material require a written permission. Abbreviations used in the figures should be explained in the corresponding legend.
Presentation of references
The references should be mentioned in the text by their numbers in square brackets (, [1, 2], [3-5]) and classified in order of appearance in the article. Mention all the names of the authors, followed by the initials of their first names without a dot; beyond 4 authors mention only the first 3, followed by et al. Journal titles are abbreviated, without dots and in italics. Page numbers are abbreviated as 100-12 instead of 100-112.
A Endnote file containing the médecine/sciences style can be downloaded on the Endnote website.
The direct link is: http://endnote.com/downloads/styles/medecinesciences.
Sivori S, Falco M, Della Chiesa M, et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004 ; 101 : 10116-21.
Kupiec JJ, Sonigo P. Ni Dieu ni gène. Paris : Seuil, 2004 : 230 p.
Ménard D, Beaulieu JF, Boudreau F, et al. Gastrointestinal tract. In : Unsicker K, Krieglstein K, eds. Cell signaling and growth factors. New York : Wiley, 2005 : 755-90.
The authors are requested to mention any potential conflict or link concerning the manuscript submitted for publication in m/s, in particular financial. This information will be kept confidential until the publication of the article.
Phone : +33 (0) 6 09 34 98 84